Promotion and new appointment at Lipoxen
This article was originally published in Scrip
Executive Summary
The UK biopharmaceutical company Lipoxen has promoted Dr Peter Laing from director of business development to chief operating officer, and appointed Dr Ajay Agrawal head of business development. Dr Laing joined Lipoxen in March 2002 and has played a leading role in developing the company's R&D and business development operations. Dr Agrawal has extensive experience in the biotech and pharma industry and was a founder of the drug delivery company polyMASC Pharmaceuticals.